Featured Question

Considering the existing data, what is the potential role of anti-angiogenic therapy in the management of patients with cervical cancer? How can we balance the costs and potential toxicities of these agents with potential benefits, and is it possible to identify patients or predict who might be more likely to benefit from this therapy?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

09-04-2014

Practical Considerations in the Management of Patients With Ulcerative Colitis

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

08-04-2014

The Expanding Role of Biologic Therapies for Ulcerative Colitis: Assessing the State of the Science and Implications for Practice

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

07-11-2014

Practical Considerations for the Management of Alzheimer’s Disease: Tools for Recognition of Early Disease and Nuances of Individualized Treatment Selection

Course Director
Anton P. Porsteinsson, MD
University of Rochester
School of Medicine and Dentistry
Rochester, New York

07-04-2014

Q&A: Assessing the Evolving Role of Angiogenesis-Targeting Agents in the Treatment of Gynecologic Cancers

Course Director
Maurie Markman, MD
Cancer Treatment Centers of America
Drexel University School of Medicine
Philadelphia, Pennsylvania

06-05-2014

Therapeutic Advances in Alzheimer’s Disease: Improving Adherence, Early Treatment Initiation, and Disease-Modifying Agents

Course Director
Gary W. Small, MD
David Geffen School of
Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
Stewart & Lynda Resnick Neuropsychiatric Hospital
Los Angeles, California

04-25-2014

Current Perspectives and Emerging Directions in Molecular Testing for Lung Cancer

Course Director
Anjali Saqi, MD
Columbia University Medical Center
New York, New York

Photo Courtesy of
Columbia Technology Ventures

04-10-2014

Current and Emerging Imaging Techniques in Multiple Sclerosis: Where Are We Now and Where Are We Going?

Course Director
Robert Naismith, MD
Washington University
School of Medicine
St. Louis, Missouri

03-25-2014

Best Practices for Molecular Testing to Guide Optimal Treatment Selection for Patients With Lung Cancer

Course Director
Anjali Saqi, MD
Columbia University Medical Center
New York, New York

Photo Courtesy of
Columbia Technology Ventures

03-10-2014

Answers to Common Challenges in the Management of Patients With COPD

Course Director
Antonio R. Anzueto, MD
Professor of Medicine
University of Texas
Health Science Center at San Antonio
San Antonio, Texas

03-03-2014

From Research to Clinical Practice: What’s New in the Treatment of Cystic Fibrosis?

Course Director
Stanley B. Fiel, MD, FACP, FCCP
The Icahn School of Medicine at
Mount Sinai
Atlantic Health System
Morristown Medical Center
Morristown, New Jersey